Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B

Adefovir dipivoxil (ADV) is a nucleotide analogue used in the chronic hepatitis B treatment. Proximal renal tubular dysfunction is one of the adverse effects of this agent and characterized with hypophosphatemia and osteomalacia. However, reduced bone mineral density with fracture due to ADV therapy...

Full description

Bibliographic Details
Main Authors: Sevilay Batıbay, Duygu Geler Külcü, Nilgün Mesci, Borçak Çağlar Ruhi, Zerrin Şahin, Hasan Gündoğdu
Format: Article
Language:English
Published: Galenos Yayinevi 2018-08-01
Series:Türk Osteoporoz Dergisi
Subjects:
Online Access:http://cms.galenos.com.tr/Uploads/Article_19913/TOD-24-59-En.pdf
id doaj-1621aafdb31d4765b096e3272a713c27
record_format Article
spelling doaj-1621aafdb31d4765b096e3272a713c272020-11-25T04:07:23ZengGalenos YayineviTürk Osteoporoz Dergisi2147-26532018-08-01242596210.4274/tod.04796Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis BSevilay Batıbay0Duygu Geler Külcü1Nilgün Mesci2Borçak Çağlar Ruhi3Zerrin Şahin4Hasan Gündoğdu5İstanbul Haydarpaşa Numune Training and Research Hospital, Clinic of Physical Medicine and Rehabilitation, İstanbul, Turkeyİstanbul Haydarpaşa Numune Training and Research Hospital, Clinic of Physical Medicine and Rehabilitation, İstanbul, Turkeyİstanbul Haydarpaşa Numune Training and Research Hospital, Clinic of Physical Medicine and Rehabilitation, İstanbul, Turkeyİstanbul Haydarpaşa Numune Training and Research Hospital, Clinic of Nephrology, İstanbul, Turkeyİstanbul Haydarpaşa Numune Training and Research Hospital, Clinic of Physical Medicine and Rehabilitation, İstanbul, TurkeyArtvin State Hospital, Clinic of Radiology, Artvin, TurkeyAdefovir dipivoxil (ADV) is a nucleotide analogue used in the chronic hepatitis B treatment. Proximal renal tubular dysfunction is one of the adverse effects of this agent and characterized with hypophosphatemia and osteomalacia. However, reduced bone mineral density with fracture due to ADV therapy has not been reported before. We aimed to report a 55-year-old male patient with proximal femur fracture who developed hypophosphatemic osteomalacia while using low dose of adefovir (10 mg/day) for chronic hepatitis B treatment for 10 years.http://cms.galenos.com.tr/Uploads/Article_19913/TOD-24-59-En.pdfAdefovir dipivoxilhypophosphatemiaosteomalaciaosteoporosisfracture
collection DOAJ
language English
format Article
sources DOAJ
author Sevilay Batıbay
Duygu Geler Külcü
Nilgün Mesci
Borçak Çağlar Ruhi
Zerrin Şahin
Hasan Gündoğdu
spellingShingle Sevilay Batıbay
Duygu Geler Külcü
Nilgün Mesci
Borçak Çağlar Ruhi
Zerrin Şahin
Hasan Gündoğdu
Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
Türk Osteoporoz Dergisi
Adefovir dipivoxil
hypophosphatemia
osteomalacia
osteoporosis
fracture
author_facet Sevilay Batıbay
Duygu Geler Külcü
Nilgün Mesci
Borçak Çağlar Ruhi
Zerrin Şahin
Hasan Gündoğdu
author_sort Sevilay Batıbay
title Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
title_short Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
title_full Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
title_fullStr Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
title_full_unstemmed Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
title_sort pathological femoral fracture due to osteoporosis and hypophosphatemic osteomalacia following adefovir therapy in a patient with chronic hepatitis b
publisher Galenos Yayinevi
series Türk Osteoporoz Dergisi
issn 2147-2653
publishDate 2018-08-01
description Adefovir dipivoxil (ADV) is a nucleotide analogue used in the chronic hepatitis B treatment. Proximal renal tubular dysfunction is one of the adverse effects of this agent and characterized with hypophosphatemia and osteomalacia. However, reduced bone mineral density with fracture due to ADV therapy has not been reported before. We aimed to report a 55-year-old male patient with proximal femur fracture who developed hypophosphatemic osteomalacia while using low dose of adefovir (10 mg/day) for chronic hepatitis B treatment for 10 years.
topic Adefovir dipivoxil
hypophosphatemia
osteomalacia
osteoporosis
fracture
url http://cms.galenos.com.tr/Uploads/Article_19913/TOD-24-59-En.pdf
work_keys_str_mv AT sevilaybatıbay pathologicalfemoralfractureduetoosteoporosisandhypophosphatemicosteomalaciafollowingadefovirtherapyinapatientwithchronichepatitisb
AT duygugelerkulcu pathologicalfemoralfractureduetoosteoporosisandhypophosphatemicosteomalaciafollowingadefovirtherapyinapatientwithchronichepatitisb
AT nilgunmesci pathologicalfemoralfractureduetoosteoporosisandhypophosphatemicosteomalaciafollowingadefovirtherapyinapatientwithchronichepatitisb
AT borcakcaglarruhi pathologicalfemoralfractureduetoosteoporosisandhypophosphatemicosteomalaciafollowingadefovirtherapyinapatientwithchronichepatitisb
AT zerrinsahin pathologicalfemoralfractureduetoosteoporosisandhypophosphatemicosteomalaciafollowingadefovirtherapyinapatientwithchronichepatitisb
AT hasangundogdu pathologicalfemoralfractureduetoosteoporosisandhypophosphatemicosteomalaciafollowingadefovirtherapyinapatientwithchronichepatitisb
_version_ 1724429012108836864